Seeking Alpha

The FTC yesterday said pharmaceutical companies are delaying generic competition by making...

The FTC yesterday said pharmaceutical companies are delaying generic competition by making patent settlement agreements in which they pledge not to launch their own copycat medicines. The FTC made the comments in a case involving CVS and Rite Aid (RAD), which are suing Pfizer (PFE) and TEVA for conspiring to keep generic versions of the antidepressant Effexor XR out of stores.
Comments (4)
  • tomami
    , contributor
    Comments (112) | Send Message
     
    Are you telling me that the Federal Government can demand a private company to manufacture and sell a certain product even if they do not want to do it? They not only want to punish the tobacco companies for selling a legal product, but now they want to make sure all these pharmaceutical companies manufacture generic drugs when the patents expire.
    14 Aug 2012, 08:42 AM Reply Like
  • jcole643@cinci.rr.com
    , contributor
    Comments (10) | Send Message
     
    It has the same effect as price collusion and involves a quid pro quo. Clear anticompetitive behavior. Big antitrust beat-down coming...
    14 Aug 2012, 09:06 AM Reply Like
  • flyinby77
    , contributor
    Comments (3) | Send Message
     
    Long overdue and will be boon for the consumer.
    14 Aug 2012, 01:39 PM Reply Like
  • vr39235
    , contributor
    Comments (4) | Send Message
     
    These are the very things that the Feds allowed in the first place! The various agencies within government are just adding layers of bureaucracy! Why didn't the FDA, or even the Justice Dept put a stop to this when the patent came to expiration in the first place? CVS & Rite-Aid should be suing the Feds, NOT the drug companies! The more lawsuits against drug companies (and they are piling up), the more our healthcare costs go up.
    14 Aug 2012, 02:03 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|